Beta · Launching 1 October 2026 (). Features may change. Feedback welcome at contact@ampliova.com

Legal

Terms of Service

Last updated: 27 August 2026

1. Publisher and legal notice

Ampliova is published by Louis Müller, micro-entrepreneur (France).

  • Address: 21 Avenue Pauline, 94000 Créteil, France
  • SIRET: 108 830 514 00015
  • Code APE/NAF: 63.11Z – Traitement de données, hébergement et activités connexes
  • TVA: Non applicable (article 293 B du CGI)
  • Publication director: Louis Müller
  • Contact: contact@ampliova.com

Hosting providers:

  • Vercel Inc., 340 Pine Street, Suite 701, San Francisco, CA 94104, USA (EU region deployment)
  • Supabase, EU West, Ireland (database, auth and file storage)
  • Railway Corp., San Francisco, CA, USA (analysis engine)

2. Acceptance of these terms

By creating an account or using any feature of Ampliova, you acknowledge that you have read, understood, and agree to be bound by these Terms of Service and the Privacy Policy.

If you are accessing Ampliova on behalf of an institution or employer, you represent that you have authority to bind that organisation to these terms, in which case "you" refers to that organisation.

These terms constitute a contract between you and the publisher. If you do not agree, do not use the service.

3. Service description

Ampliova is a web-based application for quantitative PCR (qPCR) data analysis. It implements efficiency-corrected relative quantification (Untergasser et al., 2021; Müller and Tiret, 2026), geometric mean normalization across multiple reference genes (Vandesompele et al., 2002), reference gene stability evaluation (Vandesompele et al., 2002; Andersen et al., 2004; Pfaffl et al., 2004), and follows MIQE 2.0 guidelines (Bustin et al., 2025) by default.

Research use only. The service is provided exclusively for research purposes. It is not a certified medical device and must not be used for clinical diagnostics, patient care, or any decision with direct consequences on human health, without prior independent expert validation.

4. Beta programme

Ampliova is currently in a closed beta phase (until October 2026). During this period:

  • Access is granted by invitation only. Accounts are created by the publisher.
  • The service is provided free of charge. No payment is collected.
  • Features, interface, and data formats may change without prior notice.
  • The service may be interrupted for maintenance or updates at any time.
  • We may collect feedback from beta testers to improve the service. No feedback will be published or attributed without explicit consent.

Beta testers may request deletion of their account and associated data at any time by contacting contact@ampliova.com or from the Settings page.

The remaining sections of these terms apply in full during the beta period. Sections relating to payment (5) and consumer mediation (6) will become effective once paid plans are introduced.

5. Account and access

By registering, you agree to:

  • Provide accurate, current registration information.
  • Keep your credentials confidential and not share them with third parties.
  • Notify us immediately of any unauthorised use of your account.
  • Use the service only for lawful research purposes.
  • Not create accounts on behalf of third parties without their consent.

Prohibited uses include, without limitation:

  • Automated or robotic access, scraping, or bulk data extraction beyond normal API use.
  • Attempting to gain unauthorised access to other users' data or to back-end systems.
  • Using the service to process personal health data of identified patients.
  • Uploading files containing malicious code or designed to disrupt the service.
  • Circumventing usage limits, tier restrictions, or authentication mechanisms.

We reserve the right to suspend or permanently terminate accounts that violate these terms. Where feasible, we will give reasonable notice before termination unless the violation is severe.

6. Plans, pricing and payment

Ampliova is offered in three tiers: Free, Researcher, and Lab. Paid plans are billed annually. The Lab plan is priced per seat with a minimum of 3 seats. Prices are displayed in euros, exclusive of any applicable tax.

Standard online subscriptions are purchased by card through our payment processor, Stripe. For these transactions, Stripe acts as the seller of record (merchant of record) and is responsible for calculating, collecting, and remitting any applicable indirect tax (VAT or equivalent) shown at checkout.

Institutional billing. Institutions that need to pay by purchase order or bank transfer instead of card can contact contact@ampliova.com to arrange billing directly with Ampliova. For these arrangements, Ampliova is the seller of record. Ampliova currently operates under the VAT exemption scheme for small businesses (franchise en base, article 293 B of the French Tax Code): invoices issued directly by Ampliova do not include VAT (TVA non applicable, art. 293 B du CGI). This may change if Ampliova's turnover exceeds the applicable threshold, in which case VAT will be added and stated on the invoice.

Subscriptions renew automatically unless cancelled before the renewal date. You may cancel at any time from the Billing section of your Settings. Upon cancellation, paid access continues until the end of the current billing period; no partial refund is issued for unused time on annual plans.

Right of withdrawal (B2C consumers only). If you are a consumer (acting for personal purposes outside any trade, business, or profession) and reside in the European Union, you have the right to withdraw from a subscription contract within 14 days of purchase, without giving any reason. For standard online subscriptions, this right may be administered directly by Stripe as seller of record; for subscriptions arranged directly with Ampliova (institutional billing), or if you have any question about withdrawal, contact contact@ampliova.com before the 14-day period expires. If you have expressly requested that the service begin before the end of the withdrawal period, you agree to pay for the service proportionally used up to the date of withdrawal.

Note: this right of withdrawal does not apply to professional or institutional subscribers (B2B).

In case of billing dispute, contact contact@ampliova.com. We commit to responding within 14 business days.

7. Consumer mediation

Pursuant to Articles L. 612-1 et seq. of the French Consumer Code, any unresolved consumer dispute may be referred to a certified mediator free of charge.

Our designated mediator is: [Consumer mediator: to complete before launch]
Website: https://[mediator-url]

The European Commission also provides an Online Dispute Resolution platform at ec.europa.eu/consumers/odr.

Mediation applies to consumers only (B2C). Professional and institutional users are not entitled to consumer mediation.

8. Your research data

You retain full ownership of all data you upload to Ampliova (plate files, Cq values, sample layouts, results). We process this data solely to provide the analysis service for you, and for no other purpose.

We do not share, sell, licence, or use your research data for training AI models or for any commercial purpose beyond operating the service.

You may export your results and delete your account and all associated data at any time from the Settings page. Data is permanently deleted within 30 days of account deletion.

For full details on data processing, sub-processors, retention periods, and your GDPR rights, see the Privacy Policy.

9. Intellectual property

The Ampliova software, interface design, and documentation are the exclusive property of the publisher. You may not copy, modify, distribute, sublicence, sell, or reverse-engineer any part of the service, except as expressly permitted by law.

Ampliova implements published scientific methods: LinRegPCR (Ruijter et al. 2021, BMC Bioinformatics), geNorm (Vandesompele et al. 2002), NormFinder (Andersen et al. 2004), and related algorithms. Attribution to the original authors is maintained throughout the application and must be preserved in any publication using results produced by Ampliova.

Your research data, results, and any derivative works you create using the service remain entirely your intellectual property.

Certain third-party trademarks are referenced within the application solely to identify compatible products and help users configure their analyses. QIAGEN® and RT² Profiler® are registered trademarks of QIAGEN N.V. Bio-Rad® and PrimePCR® are registered trademarks of Bio-Rad Laboratories, Inc. Ampliova is an independent tool and is not affiliated with, endorsed by, or in any way associated with QIAGEN, Bio-Rad, or any other instrument or reagent manufacturer whose products may be used to generate data analysed by this service.

10. Warranties and limitation of liability

Ampliova is provided on an "as is" and "as available" basis. We make no warranty, express or implied, that the service will be error-free, uninterrupted, or fit for any particular purpose beyond the described functionality.

You are solely responsible for independently validating any scientific conclusions drawn from Ampliova's analysis before publication, submission to a regulatory body, or use in any decision with significant consequences.

To the maximum extent permitted by applicable law, our total liability for any claim arising from your use of the service is limited to the amount you paid in the 12 months preceding the claim. We are not liable for indirect, incidental, or consequential damages, including loss of data, loss of research results, or reputational harm.

Nothing in these terms excludes liability for death or personal injury caused by our negligence, or for fraud or fraudulent misrepresentation.

11. Service availability and force majeure

We aim for high availability but do not guarantee uninterrupted service. Planned maintenance will be announced in advance where feasible. We are not liable for downtime caused by third-party infrastructure providers (Vercel, Supabase, Railway) or by events beyond our reasonable control.

Neither party shall be liable for failure or delay in performance due to causes beyond their reasonable control, including but not limited to natural disasters, war, government actions, cyberattacks, internet or infrastructure outages (force majeure).

12. Modifications to these terms

We may update these terms at any time. For material changes, registered users will be notified by email at least 14 days before the change takes effect. Continued use of the service after that date constitutes acceptance of the updated terms. If you do not agree to the new terms, you must stop using the service and may delete your account.

14. Miscellaneous

Severability. If any provision of these terms is found to be unenforceable or invalid, that provision will be limited or eliminated to the minimum extent necessary, and the remaining provisions will continue in full force.

Non-waiver. Our failure to enforce any provision of these terms does not constitute a waiver of our right to enforce that provision in the future.

Assignment. You may not assign your rights or obligations under these terms without our prior written consent. We may assign our rights and obligations in connection with a merger, acquisition, or sale of assets.

Entire agreement. These terms, together with the Privacy Policy, constitute the entire agreement between you and the publisher regarding the service and supersede any prior agreements.

15. Governing law and jurisdiction

These terms are governed by French law, excluding its conflict of law provisions.

For consumers in the EU: nothing in these terms deprives you of the protection afforded by the mandatory provisions of the law of your country of residence.

Any dispute not resolved through the mediation procedure described in Section 7 shall be submitted to the exclusive jurisdiction of the competent courts of France.

For any questions about these terms: contact@ampliova.com